Cargando…
Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy
A large number of human diseases are caused by chronic tissue injury with fibrosis potentially leading to organ failure. There is a need for more effective anti-fibrotic therapies. Congenital muscular dystrophy type 1A (MDC1A) is a devastating form of muscular dystrophy caused by laminin α2 chain-de...
Autores principales: | Gawlik, Kinga I., Holmberg, Johan, Svensson, Martina, Einerborg, Mikaela, Oliveira, Bernardo M. S., Deierborg, Tomas, Durbeej, Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345027/ https://www.ncbi.nlm.nih.gov/pubmed/28281577 http://dx.doi.org/10.1038/srep44059 |
Ejemplares similares
-
Early skeletal muscle pathology and disease progress in the dy(3K)/dy(3K) mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2019) -
Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Körner, Zandra, et al.
Publicado: (2016) -
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
por: Gawlik, Kinga I, et al.
Publicado: (2011) -
Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma
por: Holmberg, Johan, et al.
Publicado: (2014) -
Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain Deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2010)